Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantification of maternal and fetal valaciclovir exposure in a pharmacokinetic study of cytomegalovirus-infected pregnant women treated to prevent vertical transmission.
Faure-Bardon V, Bouazza N, Benaboud S, Foissac F, Rouillon S, Froelicher-Bournaud L, Leruez-Ville M, Guilleminot T, Lui G, Tréluyer JM, Ville Y. Faure-Bardon V, et al. Among authors: froelicher bournaud l. J Antimicrob Chemother. 2025 Jan 15:dkae470. doi: 10.1093/jac/dkae470. Online ahead of print. J Antimicrob Chemother. 2025. PMID: 39810739
Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an in vitro model.
Thy M, Kecili F, Urien S, Bouazza N, Foissac F, Froelicher Bournaud L, Rouillon S, Benaboud S, Lesage F, Tréluyer JM, Lui G, Oualha M. Thy M, et al. Among authors: froelicher bournaud l. Expert Opin Drug Metab Toxicol. 2024 Dec 22:1-9. doi: 10.1080/17425255.2024.2443754. Online ahead of print. Expert Opin Drug Metab Toxicol. 2024. PMID: 39692096
Population Pharmacokinetics of Intravenous Paracetamol and Its Metabolites in Extreme Preterm Neonates in the Context of Patent Ductus Arteriosus Treatment.
Padavia F, Treluyer JM, Cambonie G, Flamant C, Rideau A, Tauzin M, Patkai J, Gascoin G, Lumia M, Aikio O, Foissac F, Urien S, Benaboud S, Lui G, Froelicher Bournaud L, Zheng Y, Kemper R, Tortigue M, Baruteau AE, Kallio J, Hallman M, Diallo A, Levoyer L, Roze JC, Bouazza N. Padavia F, et al. Among authors: froelicher bournaud l. Clin Pharmacokinet. 2024 Dec;63(12):1689-1700. doi: 10.1007/s40262-024-01439-3. Epub 2024 Nov 22. Clin Pharmacokinet. 2024. PMID: 39578300 Free PMC article.
Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on: 'Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions'.
Maillard A, Froelicher Bournaud L, Pastre J, Planquette B, Parize P, Lanternier F, Rasmussen C, Chenevier-Gobeaux C, Cheurfa C, Benaboud S, Charlier C, Canouï E. Maillard A, et al. Among authors: froelicher bournaud l. J Antimicrob Chemother. 2024 Sep 3;79(9):2403-2405. doi: 10.1093/jac/dkae258. J Antimicrob Chemother. 2024. PMID: 39106846 No abstract available.
A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma.
Zheng Y, Rouillon S, Khemakhem M, Balakirouchenane D, Lui G, Abdalla S, Sanoufi MR, Sauvaitre L, Thebault L, Hirt D, Treluyer JM, Gana I, Benaboud S, Froelicher-Bournaud L. Zheng Y, et al. Among authors: froelicher bournaud l. J Pharm Biomed Anal. 2024 Sep 15;248:116322. doi: 10.1016/j.jpba.2024.116322. Epub 2024 Jun 24. J Pharm Biomed Anal. 2024. PMID: 38964167
Cefotaxime diffusion in the vitreous humour: a pharmacokinetic case series.
Shalaby A, Benaboud S, Dedieu D, Anjou M, Rasmussen C, Brezin A, Richebe P, Froelicher Bournaud L, Rouillon S, Guyonnet C, Poyart C, Charlier C, Canouï E. Shalaby A, et al. Among authors: froelicher bournaud l. J Antimicrob Chemother. 2024 Aug 1;79(8):2077-2078. doi: 10.1093/jac/dkae195. J Antimicrob Chemother. 2024. PMID: 38863388 No abstract available.
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy.
Bouazza N, Urien S, Foissac F, Choupeaux L, Lui G, Froelicher Bournaud L, Rouillon S, Zheng Y, Bardin E, Stremler N, Bessaci K, Bihouee T, Coirier-Duet E, Marguet C, Deneuville E, Laurans M, Reix P, Gerardin M, Mittaine M, Epaud R, Thumerelle C, Weiss L, Berthaud R, Semeraro M, Treluyer JM, Benaboud S, Sermet-Gaudelus I. Bouazza N, et al. Among authors: froelicher bournaud l. Clin Pharmacokinet. 2024 Mar;63(3):333-342. doi: 10.1007/s40262-023-01342-3. Epub 2024 Feb 4. Clin Pharmacokinet. 2024. PMID: 38310629
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial.
Abdalla S, Compagnucci A, Riault Y, Chan MK, Bamford A, Nolan A, Ramos JT, Constant V, Nguyen T-N, Zheng Y, Tréluyer J-M, Froelicher-Bournaud L, Neveux N, Saidi Y, Cressey TR, Hirt D; SMILE study group. Abdalla S, et al. Among authors: froelicher bournaud l. Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0100423. doi: 10.1128/aac.01004-23. Epub 2023 Dec 11. Antimicrob Agents Chemother. 2024. PMID: 38092664 Free PMC article.